Suchergebnisse - "Calabresi, Peter A"
-
1
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
ISSN: 1095-9203, 1095-9203Veröffentlicht: United States 27.04.2018Veröffentlicht in Science (American Association for the Advancement of Science) (27.04.2018)“… Activated immune cells undergo a metabolic switch to aerobic glycolysis akin to the Warburg effect, thereby presenting a potential therapeutic target in …”
Weitere Angaben
Journal Article -
2
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 30.09.2021Veröffentlicht in Nature (London) (30.09.2021)“… Multiple sclerosis (MS) lesions that do not resolve in the months after they form harbour ongoing demyelination and axon degeneration, and are identifiable in …”
Volltext
Journal Article -
3
Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination
ISSN: 2041-1723, 2041-1723Veröffentlicht: London Nature Publishing Group UK 29.08.2019Veröffentlicht in Nature communications (29.08.2019)“… Oligodendrocyte precursor cells (OPCs) are abundant in the adult central nervous system, and have the capacity to regenerate oligodendrocytes and myelin …”
Volltext
Journal Article -
4
Diffusion‐time dependence of diffusional kurtosis in the mouse brain
ISSN: 0740-3194, 1522-2594, 1522-2594Veröffentlicht: United States Wiley Subscription Services, Inc 01.09.2020Veröffentlicht in Magnetic resonance in medicine (01.09.2020)“… Purpose To investigate diffusion‐time dependency of diffusional kurtosis in the mouse brain using pulsed‐gradient spin‐echo (PGSE) and oscillating‐gradient …”
Volltext
Journal Article -
5
Imaging chronic active lesions in multiple sclerosis: a consensus statement
ISSN: 1460-2156, 1460-2156Veröffentlicht: England 03.09.2024Veröffentlicht in Brain (London, England : 1878) (03.09.2024)“… Chronic active lesions (CAL) are an important manifestation of chronic inflammation in multiple sclerosis and have implications for non-relapsing biological …”
Weitere Angaben
Journal Article -
6
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
ISSN: 1474-4422, 1474-4465, 1474-4465Veröffentlicht: England Elsevier Ltd 01.09.2010Veröffentlicht in Lancet neurology (01.09.2010)“… Optical coherence tomography (OCT) is a new method that could aid analysis of neurodegeneration in multiple sclerosis (MS) by capturing thinning of the retinal …”
Volltext
Journal Article -
7
Synaptic and complement markers in extracellular vesicles in multiple sclerosis
ISSN: 1477-0970, 1477-0970Veröffentlicht: England 01.04.2021Veröffentlicht in Multiple sclerosis (01.04.2021)“… Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement …”
Weitere Angaben
Journal Article -
8
Structured layer surface segmentation for retina OCT using fully convolutional regression networks
ISSN: 1361-8415, 1361-8423, 1361-8423Veröffentlicht: Netherlands Elsevier B.V 01.02.2021Veröffentlicht in Medical image analysis (01.02.2021)“… •A novel formulation of deep network to output continuous, smooth and topology correct surfaces without post-processing.•End-to-end optimization of multiple …”
Volltext
Journal Article -
9
DeepHarmony: A deep learning approach to contrast harmonization across scanner changes
ISSN: 0730-725X, 1873-5894, 1873-5894Veröffentlicht: Netherlands Elsevier Inc 01.12.2019Veröffentlicht in Magnetic resonance imaging (01.12.2019)“… Magnetic resonance imaging (MRI) is a flexible medical imaging modality that often lacks reproducibility between protocols and scanners. It has been shown that …”
Volltext
Journal Article -
10
Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior
ISSN: 0142-9612, 1878-5905, 1878-5905Veröffentlicht: Netherlands Elsevier Ltd 01.01.2019Veröffentlicht in Biomaterials (01.01.2019)“… Microvessels of the blood-brain barrier (BBB) regulate transport into the brain. The highly specialized brain microvascular endothelial cells, a major …”
Volltext
Journal Article -
11
Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition
ISSN: 1460-2156, 1460-2156Veröffentlicht: England 16.03.2021Veröffentlicht in Brain (London, England : 1878) (16.03.2021)“… Leptomeningeal inflammation in multiple sclerosis is associated with worse clinical outcomes and greater cortical pathology. Despite progress in identifying …”
Weitere Angaben
Journal Article -
12
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
ISSN: 1474-4422, 1474-4465, 1474-4465Veröffentlicht: England Elsevier Ltd 01.06.2014Veröffentlicht in Lancet neurology (01.06.2014)“… Fingolimod has shown reductions in clinical and MRI disease activity in patients with relapsing-remitting multiple sclerosis. We further assessed the efficacy …”
Volltext
Journal Article -
13
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)
ISSN: 1091-6490, 1091-6490Veröffentlicht: United States 29.01.2019Veröffentlicht in Proceedings of the National Academy of Sciences - PNAS (29.01.2019)“… While neuroinflammation is an evolving concept and the cells involved and their functions are being defined, microglia are understood to be a key cellular …”
Weitere Angaben
Journal Article -
14
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
ISSN: 1474-4422, 1474-4465Veröffentlicht: London Elsevier Ltd 01.07.2014Veröffentlicht in Lancet neurology (01.07.2014)“… Subcutaneous pegylated interferon (peginterferon) beta-1a is being developed for treatment of relapsing multiple sclerosis, with less frequent dosing than …”
Volltext
Journal Article -
15
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein
ISSN: 1091-6490, 1091-6490Veröffentlicht: United States 13.08.2013Veröffentlicht in Proceedings of the National Academy of Sciences - PNAS (13.08.2013)“… Chronic immune activation is a major complication of antiretroviral therapy (ART) for HIV infection and can cause a devastating immune reconstitution …”
Weitere Angaben
Journal Article -
16
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
ISSN: 2352-3964, 2352-3964Veröffentlicht: Netherlands Elsevier B.V 01.03.2024Veröffentlicht in EBioMedicine (01.03.2024)“… Neurofilament light chain (NfL) is a long-awaited blood biomarker that can provide clinically useful information about prognosis and therapeutic efficacy in …”
Volltext
Journal Article -
17
Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
ISSN: 1662-5099, 1662-5099Veröffentlicht: Lausanne Frontiers Research Foundation 03.11.2022Veröffentlicht in Frontiers in molecular neuroscience (03.11.2022)“… Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS). In people with MS, …”
Volltext
Journal Article -
18
AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis
ISSN: 1664-2295, 1664-2295Veröffentlicht: Frontiers Media S.A 08.10.2020Veröffentlicht in Frontiers in neurology (08.10.2020)“… Background: Optic neuritis (ON) is a cardinal manifestation of multiple sclerosis (MS), aquaporin-4 (AQP4)-IgG-, and myelin oligodendrocyte glycoprotein …”
Volltext
Journal Article -
19
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis
ISSN: 1526-632X, 1526-632XVeröffentlicht: United States 26.01.2016Veröffentlicht in Neurology (26.01.2016)“… To study the safety profile and characterize the immunologic effects of high- vs low-dose cholecalciferol supplementation in patients with multiple sclerosis …”
Weitere Angaben
Journal Article -
20
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
ISSN: 0140-6736, 1474-547X, 1474-547XVeröffentlicht: Kidlington Elsevier Ltd 19.11.2011Veröffentlicht in The Lancet (British edition) (19.11.2011)“… B lymphocytes are implicated in the pathogenesis of multiple sclerosis. We aimed to assess efficacy and safety of two dose regimens of the humanised anti-CD20 …”
Volltext
Journal Article